Stockreport

Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in March

Impel Pharmaceuticals Inc.  (IMPL) 
PDF SEATTLE, March 03, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies fo [Read more]